The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Hasani Ranjbar, Shirin ^a   Jouyandeh, Zahra ^a   Qorbani, Mostafa ^a   Hemmatabadi, Mahbubeh ^a   Larijani, Bagher ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angipars ; Bone turnover markers; Diabetes mellitus type 2; Semelil

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ANGIPARS; CALCIUM; CREATININE; HERBACEOUS AGENT; NEW DRUG; OSTEOCALCIN; PYRIDINOLINE; SEMELIL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE TURNOVER; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC PATIENT; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OSSIFICATION; OSTEOLYSIS; RANDOMIZED CONTROLLED TRIAL; SECONDARY OSTEOPOROSIS; TREATMENT DURATION;

EID: 84872388236     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-84     Document Type: Article

References (25)

1. Diabetes mellitus a risk factor for osteoporosis? Leidig-Bruckner G, Zeigler R, Exp Clin Endocrinol Diabetes 2001 109 suppl2 493 s514 11460594
2. Osteoporosis: a still increasing prevalence. Reginster JY, Burlet N, Bone 2006 38 4 S9 16455317
3. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Altindag O, Erel O, Soran N, Celik H, Selek S, Rheumatol Int 2008 28 317 321 10.1007/s00296-007-0452-0 17823800
4. Diabetes mellitus: does it affect bone? Schwartz AV, Calcif Tissue Int 2003 73 515 519 10.1007/s00223-003-0023-7 14517715 (Pubitemid 37517795)
5. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. Vogt MT, Cauley JA, Kuller LH, Nevitt MC, J Bone Miner Res 1997 12 2 283 289 10.1359/jbmr.1997.12.2.283 9041062 (Pubitemid 27086311)
6. The hypercalciuria of diabetes mellitus: its amelioration with insulin. Raskin P, Stevenson MR, Barilla DE, Pak CY, Clin Endocrinol (Oxf) 1978 9 329 335 10.1111/j.1365-2265.1978.tb02218.x (Pubitemid 9037305)
7. Bone health and diabetes. Brandi ML, Medicographia 2010 32 364 369
8. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. Dobnig H, Piswanger-Sölkner JC, Roth M, Obermayer-Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Sieberer C, Fahrleitner-Pammer A, J Clin Endocrinol Metab 2006 91 3355 3363 10.1210/jc.2006-0460 16735485 (Pubitemid 44402104)
9. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in Type 2 diabetes mellitus. Kanazawa I, Yamaguchi T, Masahiro Y, Yamauchi M, Kurioka S, Yano S, Sugimoto T, J Clin Endocrinol Metab 2009 94 1 45 49 18984661
10. Oxidative stress, free radicals and bone remodeling. Banfi G, Lorio E, Corsi M, Clin Chem Lab Med 2008 46 11 1550 1555 18847368
11. Role of oxidative stress in diabetic bone disorder. Hamada Y, Fujii H, Fukagawa M, Bone 2009 45 35 38
12. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM, Luo SQ, Biochem Bioph Res Co 2004 314 197 207 10.1016/j.bbrc.2003.12.073 (Pubitemid 38058389)
13. Oxidative stress may be a common mechanism linking major depression and osteoporosis. Pasco JA, Nicholson GC, Ng F, Henry MJ, Williams LJ, et al. Acta Neuropsychiatr 2008 20 112 116 10.1111/j.1601-5215.2008.00283.x (Pubitemid 351724924)
14. Evaluation of acute and sub-chronic toxicity of semelil (ANGIPARS™), a new phytotherapeutic drug for wound healing in rodents. Abdollahi M, Farzamfar B, Salari P, Khorram Khorshid HR, Larijani B, Farhadi M, Madani SH, DARU 2008 16 1 7 14 (Pubitemid 351214328)
15. Effects of intravenous semelil (ANGIPARSTM) on diabetic foot ulcers healing: a multicenter clinical trial. Larijani B, Heshmat R, Bahrami A, Delshad H, Ranjbar Omrani G, Mohammad K, Heidarpour R, Mohajeri Tehrani MR, Kamali K, Farhadi M, Gharibdoust F, Madani SH, DARU 2008 6 1 35 40 (Pubitemid 351214333)
16. Overview of diabetic foot; novel treatments in diabetic foot ulcer. Larijani B, Hasani Ranjbar S, DARU 2008 16 supplement 1 1 6 (Pubitemid 351214327)
17. Effects of melilotus officinalis on acute inflammation. Luminita P-M, Alina Elena P, Pârvu M, Taamas M, Buia R, Puia M, Phytother Res 2002 16 316 319 10.1002/ptr.875 12112285 (Pubitemid 34700267)
18. Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. Sheweita SA, Khoshhal KI, Curr Drug Metab 2007 8 5 519 525 17584023 (Pubitemid 47603416)
19. Effects of vitamin K on bone mass and bone metabolism. Verneer C, Gisbers B, Craciun A, Greonen-Van Dooren M, Knapen M, J Nutr 1996 126 1187s 1191s 8642454 (Pubitemid 26105656)
20. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Hasani-Ranjbar S, Larijani B, Abdollahi M, Arch Med Sci 2008 4 3 285 292
21. A systematic review of efficacy and safety of urtica dioica in the treatment of diabetes. Mehri A, Hasani Ranjbar S, Larijani B, Abdollahi M, Int J Pharmacol 2011 7 2 161 170
22. Benefits of angipars on oxidant-antioxidant balance in diabetic patients; a randomized, double-blind placebo controlled clinical trial. Hemmatabadi M, Abdollahi M, Bakhshayeshi S, Heshmat R, Baeeri M, Azimaraghi O, Larijani B, DARU 2010 17 1 50 55
23. Effect of electromagnetic form of melilotus officinalis extract on dermal wound healing in diabetic mice. Farzamfar B, Minaie B, Mobtaker M, Salari P, Khorasani R, Abdollahi M, Pharmacologyonline 2008 2 246 254
24. Inhibitory effect of natural coumarin compounds, esculetin and 25. esculin, on oxidative DNA damage and formation of aberrant crypt foci and tumors induced by 1,2- dimethylhydrazine in rat colons. Kaneko T, Tahara S, Takabayashi F, Biol Pharm Bull 2007 30 11 2052 2057 10.1248/bpb.30.2052 17978474 (Pubitemid 350097038)
25. Anthraquinone compounds from morinda officinalis inhibits osteoclastic bone resorption in vitro. Leilei B, Luping Q, Lei L, Yanbin W, Ting H, Liming X, Qiaoyan Z, Chem Biol Interact 2011 194 97 105 10.1016/j.cbi.2011.08.013 21945525